Tenderwize
Zurück zur Suche

Tocilizumab

Hospilim VZW·Diepenbeek, Belgium·Expired · Aug 10, 2026·Open·Supplies·Framework
Structured notice only
Originaltitel der Bekanntmachung

Belgium – Pharmaceutical products – Raamovereenkomst voor de levering van Tocilizumab

45/100

Opportunity Score

Needs reviewMedium complexity
SuppliesFrameworkExpired
Warum diese Bewertung?

Chance

45 / 100

Komplexität

40 / 100

Risikofaktoren

The estimated contract value is not disclosed. This makes it hard to evaluate the financial opportunity and bid prepara...

The tender is only in Dutch (NLD). Non-Dutch speaking suppliers may struggle to understand requirements and submit comp...

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Eckdaten der Ausschreibung

Öffentlicher Auftraggeber
Hospilim VZW
Land
Belgien
CPV
33600000 - Pharmaceutical products +2 weitere
Frist
Aug 10, 2026

Überblick

Moderate opportunity

Wichtige Fakten

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration 24 MONTH
  • Supply of the pharmaceutical product Tocilizumab
  • Framework agreement with duration of 24 months (with possibility of up to 120 months as per XML notice)
Vollständige Zusammenfassung anzeigen

This is an open procedure for a framework agreement for the supply of Tocilizumab (a medicinal product) in Belgium. The tender is managed by Hospilim VZW, a public health undertaking. The contract duration is 24 months (with a possible extension of 120 months indicated in the XML notice). The submission deadline is 2026-08-10T08:00:00 UTC. The tender is not EU-funded according to the XML notice (no-eu-funds), though structured data says EU-funded. Estimated value is not provided. The procurement documents are available online but were not analyzed in detail.

Risiken

The estimated contract value is not disclosed. This makes it hard to evaluate the financial opportunity and bid prepara...

The tender is only in Dutch (NLD). Non-Dutch speaking suppliers may struggle to understand requirements and submit comp...

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Administrative

  • Electronic submission is required
  • Tender documents must be accessed via the provided URL
  • Language of tender: Dutch (NLD)

Anforderungen können unvollständig sein.

Zuschlagskriterien

Lot 1

Cost criterion: Total net cost (weight 60, code per-exa) — 60%Quality criterion: Pharmaceutical quality and safety (weight 20, code per-exa) — 20%Quality criterion: Delivery reliability and after-sales service (weight 20, code per-exa) — 20%

Auftraggeber

Ort

Diepenbeek, BEL

Auftraggeberprofil

Profil öffnen

Kennung

0833506251_1137

Tätigkeit

Health

Lose (1)

LOT-0001

Tocilizumab

Framework agreement for the supply of Tocilizumab. The lot covers pharmaceutical products with CPV codes 33600000, 33690000, and 33652000. Performance is in Belgian subdivisions BE223, BE224, BE225.

SuppliesFrameworkEU fundedElectronic submission

Ort

BE223, Belgium

Dauer

24 MONTH

Kategorie

Pharmaceutical products

Zuschlagskriterien

Quality

Frist

Expired Aug 10, 2026

Vergabedetails

Veröffentlichungsdatum
25 Jun 2026
Sprachen
Dutch

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
441078-2026

Dokumente (2)

Ähnliche Ausschreibungen